Denali Therapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $7.2M | 349k | 20.63 |
| 2023-06-30 | $4.4M | 149k | 29.51 |
| 2023-03-31 | $3.3M | 145k | 23.04 |
| 2022-12-31 | $4.0M | 143k | 27.81 |
| 2022-09-30 | $3.8M | 123k | 30.69 |
| 2022-06-30 | $2.5M | 86k | 29.43 |
| 2022-03-31 | $3.4M | 105k | 32.18 |
| 2021-12-31 | $4.7M | 105k | 44.60 |
| 2021-09-30 | $3.3M | 66k | 50.45 |
| 2021-06-30 | $3.3M | 42k | 78.44 |
| 2021-03-31 | $2.4M | 42k | 57.11 |
| 2020-12-31 | $4.9M | 58k | 83.75 |
| 2020-09-30 | $2.1M | 58k | 35.83 |
| 2020-06-30 | $1.4M | 57k | 24.19 |
| 2020-03-31 | $2.2M | 125k | 17.50 |
| 2019-12-31 | $139k | 8.0k | 17.43 |